Stem Cell/Cord Blood Banking Global Market Report 2021: COVID-19 Growth And Change To 2030 The Business Research Company’s Stem Cell/Cord Blood Banking Global Market Report 2021: COVID-19 Growth And Change To 2030 LONDON, GREATER LONDON, UK, April 19, 2021 /EINPresswire.com/ -- Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports Increasing number of cancer patients is a major driver for the stem cell and global cord blood market. Cancer diseases such as leukemia and multiple myeloma can be treated by stem cell transplant. In stem cell transplant, treatment can be either done by autologous transplant, in which the stem cells come from the same person who gets the transplant, or by allogeneic transplant, in which the stem cells come from a matched related or unrelated donor. By using stem cells in the treatment of cancer, the blood forming stem cells which are damaged during chemotherapy can be restored. According to the American Cancer Society, in 2019, around 606,880 deaths were caused in USA due to prevalence of the cancer which can be treated by transplanting the stem cells.